Beijing Tongrentang Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Beijing Tongrentang Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Beijing Tongrentang, the average price target is ¥54.00, with a high estimate of ¥65.00 and a low estimate of ¥35.00. That is a potential upside of approximately 25.87% from the last closing price of ¥42.90 on April, 2024. If you're considering investing in 600085 stock, it's essential to look at its competitors, too.
25.87% Upside
Beijing Tongrentang Fair Value Forecast for 2023 - 2025 - 2030
Beijing Tongrentang's Price has decreased by 100.00% In the last three years, from ¥31.02 to ¥0.00. Next year, analysts are expecting Fair Value to reach ¥64.14 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000538 Stock Forecast | Yunnan Baiyao Group Co.,Ltd | Outperform |
18
|
¥55.33 | Buy/Sell | ¥65.39 | 10.25% |
| 600518 Stock Forecast | Kangmei Pharmaceutical | - |
6
|
¥2.00 | Buy/Sell | ¥25.97 | -100.00% |
| 570 Stock Forecast | China Traditional Chinese Medi... | Buy |
16
|
HK$4.30 | Buy/Sell | HK$3.98 | 0.23% |
| 300026 Stock Forecast | Tianjin Chase Sun Pharmaceutic... | Buy |
14
|
¥3.69 | Buy/Sell | ¥7.66 | 8.40% |
| 300147 Stock Forecast | Xiangxue Pharmaceutical | - |
10
|
¥4.67 | Buy/Sell | ¥49.01 | -100.00% |
Beijing Tongrentang Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Beijing Tongrentang's Revenue has grown from ¥12.83B to ¥15.37B – a 19.85% increase. Next year, analysts are expecting Revenue to reach ¥20.88B – an increase of 35.82%. Over the next seven years, the forecast is for Revenue to grow by 34.21%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600238 Stock Forecast | Hainan Yedao (Group) Co.,Ltd | - |
7
|
¥6.95 | Buy/Sell | ¥22.00 | -100.00% |
| 600222 Stock Forecast | Henan Taloph Pharmaceutical St... | - |
15
|
¥5.01 | Buy/Sell | ¥24.97 | -100.00% |
| SXTC Stock Forecast | China SXT Pharmaceuticals | - |
0
|
$2.22 | Buy/Sell | $0.00 | -100.00% |
.jpg)
Beijing Tongrentang Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Beijing Tongrentang's Dividend per Share has grown by 18.52%, rising from ¥0.27 to ¥0.32. For next year, analysts predict Dividend per Share of ¥0.53, which would mean an increase of 65.63%. Over the next seven years, experts predict that Beijing Tongrentang's Dividend per Share will grow at a rate of 86.14%.
Beijing Tongrentang EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Beijing Tongrentang's EBITDA has grown, rising from ¥2.24B to ¥2.96B – a growth of 31.76%. In the next year, analysts believe that EBITDA will reach ¥4.13B – an increase of 39.84%. For the next seven years, the forecast is for EBITDA to grow by 55.59%.
Beijing Tongrentang EBIT Forecast for 2023 - 2025 - 2030
Beijing Tongrentang's EBIT has grown In the last two years, rising from ¥1.91B to ¥2.63B – a growth of 37.85%. In the next year, analysts believe that EBIT will reach ¥4.01B – an increase of 52.36%. For the next seven years, experts predict that Beijing Tongrentang's EBIT will grow at a rate of 134.80%.
Beijing Tongrentang EPS Price Prediction Forecast for 2023 - 2025 - 2030
Beijing Tongrentang's EPS has decreased by 100.00% In the last three years, from ¥0.74 to ¥0.00. Next year, analysts are expecting EPS to reach ¥1.53 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)